Clinical Trial Update: INF108F in Infants With Food Protein Induced Proctocolitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for INF108F in infants with food protein-induced allergic proctocolitis; study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Protein-induced Allergic Proctocolitis

Drugs mentioned

• INF108F

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Infant Development, Gut Microbiome | Phase 4 | Status: COMPLETED | Results posted: 2025-11-24